Ancora Advisors’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-19,500
Closed -$196K 2405
2022
Q2
$196K Sell
19,500
-500
-3% -$5.02K 0.01% 766
2022
Q1
$200K Buy
+20,000
New +$200K ﹤0.01% 793

Other funds holding ARCK

Ancora Advisors's ARCK Position: Q3 2022 in Review

Ancora Advisors sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q3 2022, closing a stake of 19,500 shares — an estimated $196K sold.

Ancora Advisors first reported a position in ARCK in Q1 2022 and held it in 2 quarters. The position peaked at $200K in Q1 2022. 62 funds tracked by Wall St. Rank hold ARCK as of Q3 2022.

  • Ancora Advisors reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • Ancora Advisors sold 19,500 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q3 2022, an estimated $196K.
  • Ancora Advisors first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q1 2022 and held it in 2 quarters.
  • Ancora Advisors's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $200K in Q1 2022.
  • 62 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q3 2022.

Based on Ancora Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.